Back to Top
Seribantumab Biosimilar - Research Grade
$315.00 - $3,902.00
Seribantumab Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Species Reactivity
Human
Target
ERBB3ï؟½
Concentration
>1mg/ml
Isotype
IgG2 - lambda
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P21860
Shipping Conditions
Blue ice
Background
ERBB3 (HER3) is a co-receptor in the HER family that potentiates oncogenic signaling and contributes to therapeutic resistance in cancer research. Described here is a research-grade, unconjugated analog of seribantumab, a recombinant anti-HER3 monoclonal antibody intended for research use only. It is produced to in vivo standards in a low-endotoxin format and offered in scalable milligram to gram quantities suited to high-throughput programs. The reagent supports receptor-binding and pathway-inhibition functional assays, in vitro signaling screens, and in vivo tumor models of HER-family biology. Consistent quality across lots makes it a practical choice for laboratories running sustained study programs.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Write Your Own Review


















